Skip to content
★ Sign in to follow
TW

Thomas W. Chalberg

CEO
Adverum Biotechnologies, Inc.
Total declarations
10
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€5.5M

Latest filing published 11 Jun 2015 for Adverum Biotechnologies, Inc., €164k.

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

No signal scores available.

Thomas W. Chalberg: trading record in brief

This profile gathers the share dealings of Thomas W. Chalberg in Adverum Biotechnologies, Inc. Over a trading history stretching from 5 August 2014 to 10 June 2015, the count stands at 10 filings.

The open-market record consists of 5 sales worth €5.5M, with no purchase. The rest of the record consists of 1 share grant and 1 option exercise. Since January 2015: no purchases and 5 sales on the market.

Most recently, on 11 June 2015, the filings show an open-market sale worth €164k in Adverum Biotechnologies, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Thomas W. Chalberg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations